Form 4: Tivic Health COO Granted 45,000 Stock Options
Executive Compensation Disclosure
Tivic Health Systems, Inc. Chief Operating Officer Michael K. Handley was granted 45,000 employee stock options with an exercise price of $3.32 per share.
Summary
- Michael K. Handley, Chief Operating Officer of Tivic Health Systems, Inc., was granted 45,000 employee stock options.
- The options have an exercise price of $3.32 per share.
- The grant date for these options was August 6, 2025.
- The options expire on August 5, 2035.
- Vesting occurs in two stages: 50% on the first anniversary of the grant date, and the remaining 50% in twelve equal quarterly installments thereafter, leading to full vesting by the fourth anniversary of the grant date.
Sentiment
Score: 7
Explanation: The grant of stock options to a key executive is generally a positive sign of management retention and alignment with long-term company performance, though it doesn't reflect immediate operational or financial results.
Positives
- The granting of stock options aligns management's interests with shareholder value creation.
- The long vesting schedule encourages long-term commitment from the Chief Operating Officer.
Negatives
- The exercise price of $3.32 per share is a future strike price, and the current stock price is not provided, making it difficult to assess if it's in-the-money or out-of-the-money relative to the current market.
- Potential for future dilution if the options are exercised.
Risks
- Future stock price volatility could impact the value of the options.
- The options may not become in-the-money if the stock price does not exceed the exercise price of $3.32.
Future Outlook
This filing does not provide forward-looking statements or guidance beyond the vesting schedule of the granted options.
Industry Context
This Form 4 filing is a standard disclosure of executive compensation in the form of stock options, a common practice across industries to incentivize management and align their interests with long-term company performance. It does not provide broader industry trends or competitive analysis.
Stakeholder Impact
- Shareholders: Potential for long-term value creation if the stock price increases, aligning management incentives. Potential for future dilution if options are exercised.
Key Dates
| Date | Description |
|---|---|
| 08/06/2025 | Grant date of employee stock options to Michael K. Handley. |
| 08/06/2026 | First anniversary of grant date, 50% of stock options vest. |
| 08/06/2029 | Fourth anniversary of grant date, 100% of stock options vested. |
| 08/05/2035 | Expiration date of the employee stock options. |
| 08/08/2025 | Date Form 4 was signed by attorney-in-fact. |
Recommendation
holdThis Form 4 filing details a routine grant of stock options to a key executive, which is a standard compensation practice aimed at aligning management incentives with shareholder interests. It does not provide new financial performance data, strategic shifts, or significant risk factors that would warrant a change in investment recommendation. Therefore, a 'hold' recommendation is appropriate as this filing alone does not present a compelling reason to alter an existing investment thesis.
Keywords
Tivic Health Systems, TIVC, Stock Options, Executive Compensation, Form 4, Beneficial Ownership, Michael K. Handley, Chief Operating Officer
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.